dTIP / ETH Zürich
Baden, 5404, Switzerland
Location status: Recruiting
NCT Number: NCT06799897
The main goal of this study is to gain a thorough understanding, which specific factors drive the unhealthy sequelae of obesity. Therefore, the investigators want to understand:
1. What distinguishes obese persons without metabolic diseases from those with medical diseases in a cross-sectional comparison? 2. Which factors drive the conversions from metabolically healthy obesity into a metabolically unhealthy obesity in a longitudinal approach?
Interested in participating?
Request Info18 year–60 year
All sexes
Observational
Baden, 5404, Switzerland
Location status: Recruiting
The hypothesis is, that changes in the molecular regulation of adipose tissue as well as in adipose tissue cellular composition are responsible for the development of a rather metabolic healthy or unhealthy phenotype. Knowledge of these factors will be used to generate new diagnostic concepts for personalized risk prediction and will furthermore serve as the basis to develop novel strategies to target adipose tissue to improve metabolic health.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Inclusion criteria
for initially healthy group
o LDL-cholesterol < 5.0 mmol/l
Exclusion criteria
Time frame: Conversion will be driven by the occurrence of pathological findings caused by obesity (metabolic or cardiovascular pathologies). Through study completion, an average of 1 year.
The primary endpoint is the conversion (through study completions, 10 years) from obese but metabolically healthy subjects into obese patients in a pathological metabolic state, through study completion an average of 1 year.
Time frame: Conversion will be driven by the occurrence of pathological findings caused by obesity (metabolic or cardiovascular pathologies), through study completion, an average of 1 year.
The secondary endpoint is the identification of factors alone or in combination (through study completions, 10 years), that related to this conversion from healthy into pathological obesity. This includes factors like: DEXA scans, White Adipose Tissue, lipid and glucose metabolism, vital signs, physical activity, general health and quality of life status...
Contact information is provided by the study sponsor or research team.
Jörg Goldhahn, Prof.
CONTACT
Susanne Müller, MSc
CONTACT
ETH Zurich
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06411483
Body Weight, Healthy Obesity, Metabolically
Montreal, Quebec, Canada
View Trial DetailsNCT03322514
Appetite Regulation, Body Weight
London, United Kingdom
View Trial DetailsNCT03861754
Behavior, Body Weight
Oulu, Finland
View Trial DetailsNCT03875898
Body Weight, Healthy Obesity, Metabolically
Pierre-Bénite, France
View Trial Details